Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of 28.27% is 31% above its 5-year average of 21.51%, near the high end of its 5-year range (12.94%–31.50%).
1.72% below its 12-month average of 28.76%.
Reported quarterly operating margin; no daily interpolation.
OPERATING MARGIN
28.27%
OPERATING MARGIN AVG TTM
28.76%
OPERATING MARGIN AVG 3Y
23.26%
OPERATING MARGIN AVG 5Y
21.51%
OPERATING MARGIN AVG 10Y
21.30%
OPERATING MARGIN AVG 15Y
20.26%
OPERATING MARGIN AVG 20Y
20.92%
CURRENT VS TTM AVG
-1.72%
CURRENT VS 3Y AVG
+21.53%
CURRENT VS 5Y AVG
+31.43%
CURRENT VS 10Y AVG
+32.71%
CURRENT VS 15Y AVG
+39.55%
CURRENT VS 20Y AVG
+35.16%
SECTOR MEDIAN · HEALTHCARE
14.90%
median of 90 covered companies
CURRENT VS SECTOR MEDIAN
+89.73%
vs the sector median at left
Bristol-Myers Squibb Company
Market Cap
$132.14B
Operating Margin
28.27%
TTM Avg
28.76%
3Y Avg
23.26%
5Y Avg
21.51%
Market Cap
$134.24B
Operating Margin
38.59%
TTM Avg
18.66%
3Y Avg
31.09%
5Y Avg
34.52%
Market Cap
$123.70B
Operating Margin
31.28%
TTM Avg
28.70%
3Y Avg
26.89%
5Y Avg
27.25%
Market Cap
$144.25B
Operating Margin
20.42%
TTM Avg
21.31%
3Y Avg
23.25%
5Y Avg
23.28%
Market Cap
$105.97B
Operating Margin
22.03%
TTM Avg
20.93%
3Y Avg
20.75%
5Y Avg
21.02%
Market Cap
$104.10B
Operating Margin
1.62%
TTM Avg
1.41%
3Y Avg
1.42%
5Y Avg
1.37%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Bristol-Myers Squibb Company (BMY) | $132.14B | 28.27% | 28.76% | 23.26% | 21.51% |
| Vertex Pharmaceuticals Incorporated (VRTX)vs › | $134.24B | 38.59% | 18.66% | 31.09% | 34.52% |
| Intuitive Surgical, Inc. (ISRG)vs › | $123.70B | 31.28% | 28.70% | 26.89% | 27.25% |
| CVS Health Corp. (CVS)vs › | $122.58B | 2.00% | 2.43% | 2.79% | 3.48% |
| Danaher Corporation (DHR)vs › | $144.25B | 20.42% | 21.31% | 23.25% | 23.28% |
| Medtronic plc (MDT)vs › | $118.26B | 18.08% | 17.77% | 17.25% | 17.00% |
| Stryker Corporation (SYK)vs › | $105.97B | 22.03% | 20.93% | 20.75% | 21.02% |
| Pfizer Inc. (PFE)vs › | $158.39B | 25.08% | 25.29% | 24.23% | 24.05% |
| McKesson Corporation (MCK)vs › | $104.10B | 1.62% | 1.41% | 1.42% | 1.37% |
| Sanofi (SNY)vs › | $103.62B | 14.74% | 18.46% | 19.67% | 22.87% |
Gross Margin
70.2%
Operating Margin
28.3%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 31.50% |
| 2026-03-31 | 29.29% |
| 2025-12-31 | 22.50% |
| 2025-09-30 | 29.77% |
| 2025-06-30 | 30.76% |
| 2025-03-31 | 31.22% |
| 2024-12-31 | 20.51% |
| 2024-09-30 | 19.24% |
| 2024-06-30 | 21.18% |
| 2024-03-31 | 12.94% |
| 2023-12-31 | 17.01% |
| 2023-09-30 | 19.19% |
| 2023-06-30 | 17.31% |
| 2023-03-31 | 21.64% |
| 2022-12-31 | 15.03% |
| 2022-09-30 | 19.88% |
| 2022-06-30 | 22.62% |
| 2022-03-31 | 23.27% |
| 2021-12-31 | 18.64% |
| 2021-09-30 | 14.90% |
| 2021-06-30 | 13.31% |
| 2021-03-31 | 19.84% |
| 2020-12-31 | 6.60% |
| 2020-09-30 | 12.96% |
| 2020-06-30 | 9.27% |
| 2020-03-31 | 8.61% |
| 2019-12-31 | 8.82% |
| 2019-09-30 | 30.00% |
| 2019-06-30 | 32.17% |
| 2019-03-31 | 30.12% |
| 2018-12-31 | 26.62% |
| 2018-09-30 | 29.47% |
| 2018-06-30 | 9.80% |
| 2018-03-31 | 26.82% |
| 2017-12-31 | 18.88% |
| 2017-09-30 | 20.25% |
| 2017-06-30 | 29.20% |
| 2017-03-31 | 32.77% |
| 2016-12-31 | 19.02% |
| 2016-09-30 | 27.12% |
| 2016-06-30 | 23.32% |
| 2016-03-31 | 25.35% |
| 2015-12-31 | -3.06% |
| 2015-09-30 | 15.14% |
| 2015-06-30 | 2.95% |
| 2015-03-31 | 27.77% |
| 2014-12-31 | -0.02% |
| 2014-09-30 | 17.93% |
| 2014-06-30 | 7.69% |
| 2014-03-31 | 18.71% |
| 2013-12-31 | 19.41% |
| 2013-09-30 | 19.34% |
| 2013-06-30 | 15.51% |
| 2013-03-31 | 17.10% |
| 2012-12-31 | 12.43% |
| 2012-09-30 | 14.91% |
| 2012-06-30 | 22.69% |
| 2012-03-31 | 35.10% |
| 2011-12-31 | 28.93% |
| 2011-09-30 | 32.57% |
| 2011-06-30 | 31.97% |
| 2011-03-31 | 31.75% |
| 2010-12-31 | 22.21% |
| 2010-09-30 | 32.74% |
| 2010-06-30 | 31.71% |
| 2010-03-31 | 30.77% |
| 2009-12-31 | 26.97% |
| 2009-09-30 | 26.28% |
| 2009-06-30 | 25.65% |
| 2009-03-31 | 19.86% |
| 2008-12-31 | 15.56% |
| 2008-09-30 | 23.14% |
| 2008-06-30 | 24.70% |
| 2008-03-31 | 20.96% |
| 2007-12-31 | 12.63% |
| 2007-09-30 | 17.39% |
| 2007-06-30 | 17.27% |
| 2007-03-31 | 17.54% |
| 2006-12-31 | 5.13% |
| 2006-09-30 | 11.03% |
| 2006-06-30 | 21.15% |
| 2006-03-31 | 19.61% |
| 2005-12-31 | 16.66% |
| 2005-09-30 | 20.56% |
| 2005-06-30 | 22.99% |
| 2005-03-31 | 22.31% |
| 2004-12-31 | 29.47% |
| 2004-09-30 | 21.60% |
| 2004-06-30 | 21.12% |
| 2004-03-31 | 22.08% |
| 2003-12-31 | 20.28% |
| 2003-09-30 | 26.14% |
| 2003-06-30 | 24.78% |
| 2003-03-31 | 23.97% |
| 2002-12-31 | 18.40% |
| 2002-09-30 | 23.69% |
